home / stock / veru / veru news


VERU News and Press, Veru Inc. From 12/17/25

Stock Information

Company Name: Veru Inc.
Stock Symbol: VERU
Market: NASDAQ
Website: verupharma.com

Menu

Get VERU Alerts

News, Short Squeeze, Breakout and More Instantly...

VERU - Veru outlines 72-week Phase IIb PLATEAU study targeting obesity plateau population following FDA guidance

2025-12-17 12:01:29 ET More on Veru Veru Inc. (VERU) Q4 2025 Earnings Call Transcript Veru announces pricing of $25 million public offering Veru announces proposed public offering Seeking Alpha’s Quant Rating on Veru Historical earnings data fo...

VERU - Veru GAAP EPS of -$1.07 beats by $0.91

2025-12-17 06:31:01 ET More on Veru Veru announces pricing of $25 million public offering Veru announces proposed public offering Seeking Alpha’s Quant Rating on Veru Historical earnings data for Veru Financial information for Veru Re...

VERU - Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress

-- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- -- Incremental weight loss is an acceptable approvable primary endpoint with key secondary endpoints on physical function and bo...

VERU - Expected US Company Earnings on Wednesday, December 17th, 2025

General Mills Inc. (GIS) is expected to report $1.02 for Q2 2026 JBS N.V. Class A (JBS) is expected to report $0.54 for Q3 2025 Jabil Inc. (JBL) is expected to report $2.27 for Q1 2026 Micron Technology Inc. (MU) is expected to report $3.65 for Q1 2026 ABM Industries Incorporated ...

VERU - Earnings week ahead: FDX, NKE, MU, BB, CCL, ACN, and more

2025-12-14 08:07:35 ET The upcoming week may be a quiet one for earnings reports, but several notable companies are poised to grab investor attention.... Read the full article on Seeking Alpha For further details see: Earnings week ahead: FDX, NKE, MU, BB, CCL, ACN, and more

VERU - Veru to Report Fiscal Year 2025 Financial Results on December 17th

MIAMI, FL, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will host a conference call and audio webcast on Wed...

VERU - Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop

MIAMI, FL, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced multiple presentations at The Society on Sarcopenia, Ca...

VERU - Salesforce, Kroger Set To Report Earnings While Investors Look Out For JOLTS Job Openings

2025-11-29 11:00:00 ET Get ahead of the market by subscribing to Seeking Alpha's Wall Street Week Ahead, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings re...

VERU - 10 out of 11 companies beat EPS and revenue estimates this week: Earnings Scorecard

2025-11-28 11:06:08 ET U.S. markets were coming off the Thanksgiving holiday and will operate on a shorter schedule on Friday, closing at 1 p.m. ET for Black Friday.... Read the full article on Seeking Alpha For further details see: 10 out of 11 companies beat EPS and revenu...

VERU - Veru to Present Two Abstracts at ObesityWeek 2025

MIAMI, FL, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced the presentation of two abstracts at ObesityWeek 2025 t...

Previous 10 Next 10